Overview: Volibo 0.3 Tablet is an oral antidiabetic drug containing Voglibose. It helps manage postprandial (after-meal) blood glucose spikes in patients with type 2 diabetes mellitus. Key Benefits: – Controls blood sugar levels after meals – Improves overall glycemic control – May delay progression of diabetes-related complications Composition: Voglibose (0.3mg) How It Works: Voglibose inhibits intestinal enzymes that digest carbohydrates, leading to slower glucose absorption. This results in reduced post-meal spikes in blood sugar. Usage Instructions: – Take with the first bite of your meal – Follow your doctor’s prescribed dosage – Do not chew or crush the tablet Side Effects: – Flatulence – Abdominal pain – Diarrhea – Mild nausea Precautions: – Avoid in patients with severe kidney or gastrointestinal disorders – Monitor blood sugar levels regularly – Inform your doctor about all current medications Storage Instructions: – Store below 30°C – Keep in original packaging away from moisture Manufacturer: Sun Pharmaceutical Industries Ltd Disclaimer: This content is for informational purposes only and not a substitute for professional medical advice.